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Abbreviations
ASACO:   Association de Santé Communautaire [Community Health Association]
AS+AQ:   Artesunate and Amodiaquine
CSREF:   Centre de Santé de Référence [Referral Health Centre]
ACT:  Artemisinin-based Combination Therapy
CSCOM:  Centre de Santé Communautaire [Community Health Centre]
PRODESS:  Programme de Développement Sanitaire et Social        
  [Health & Social Development Programme]
RDT:  Rapid Diagnostic Test
MVW:   Malaria Village Worker
 
Médecins Sans Frontières is a humanitarian medical aid organisation providing emergency as-
sistance to populations in danger in over 60 countries.
Médecins Sans Frontières in Mali:
Médecins Sans Frontières (MSF) began its programme of assistance to Mali in 1983. MSF has 
worked in various regions of the country, supporting the national health system with training and 
emergency response (epidemics of cholera, meningitis, yellow fever and chicken pox; nutritional 
crises and natural disasters). Since August 2005, MSF has been supporting the new national 
treatment policy for malaria in the Kangaba Circle, located in the region of Koulikoro.3
Since 2005, MSF has been collaborating with the Malian health authorities to ﬁght malaria through 
the implementation of a new treatment protocol: artemisinin-based combination therapy (ACT). 
This treatment is essential for ensuring proper health care for patients. MSF therefore started a 
project within the Kangaba Circle in the region of Koulikoro in Southern Mali. The project com-
prised two essential phases.
The ﬁrst phase aimed at increasing the availability of treatment based on rapid diagnostic tests 
(RDTs) combined with ACTs in seven community health centres (CSCOMs) of the Circle. Health 
workers were trained to use the new treatment protocol, and awareness campaigns were carried 
out among the population. Right from the start of the project, RTDs and ACTs were administered 
to patients free of charge or at a low price. However, families still had to pay for consultation fees 
and other treatments. Compared to the utilisation rate of health services before MSF’s involve-
ment, many more patients sought treatment at the centres. Nevertheless, this project shows that 
the supplying of free or substantially subsidised drugs without modifying the overall fee based 
paying health care system does have its limitations.
Despite the improved availability of treatment and the better qual-
ity health care, during the ﬁrst phase (August 2005 to November 
2006), the attendance rates at CSCOMs remained overall low. The 
coverage of health care needs, particularly in regard to malaria, 
appeared to be inadequate. Based on these intermediary results, 
the project was reoriented in order to reduce ﬁnancial barriers for 
patients.
Beyond the help provided during the ﬁrst phase of the project, 
the second phase – still ongoing – is aimed at ensuring better 
accessibility. Free health care for all children under the age of 
ﬁve, combined with free care for pregnant women with fever, and 
a very low ﬁxed rate for overall care of persons over the age of ﬁve with fever, has resulted in the 
increased use of health services at the CSCOMs. Moreover, community health workers have been 
selected and trained to diagnose and treat uncomplicated malaria for free in children under 10 in 
inaccessible regions during high malaria-transmission periods.
These strategies have enabled MSF and the Kangaba Circle health authorities to have a rapid im-
pact on attendance at the health centres and thus provide a better coverage of health care needs. 
In a context where morbidity and mortality linked to malaria are signiﬁcant, and where poverty is 
widespread, free access for patients seems crucial for the rapid improvement of the health of this 
population. It also ensures that the subsidies granted to health centres actually reach the people, 
including those most vulnerable.
I. Executive summary
“For services to be      
taken up, ﬁnancial    
barriers to access have 
to be eliminated...”
The World Health Report 2005 - 
Make every mother and child count, 
WHO4
This document summarises the essential results obtained by MSF within the Kangaba Circle. It 
comprises two main parts:
> The ﬁrst refers to the initial phase of the project from August 2005 to November 2006: it re-
views the support given by MSF, the strategies, the outcomes obtained, and the conclusions and 
decisions concerning the reorientation of the project.
> The second part refers to the current phase of the project, particularly the period from De-
cember 2006 to the end of 2007: it describes the support given by MSF, the new strategies, and 
the main results and conclusions.
MSF wishes to share the positive results of this project with all partners involved in ﬁghting ma-
laria in Mali and concerned with the reduction of mortality and morbidity due to this pathology.
Beyond the Kangaba context, we hope that these results will give rise to a broad discussion 
of the provision of free health care as an essential strategy in the ﬁght against malaria in Mali 
and elsewhere, especially for the most vulnerable groups, which include pregnant women 
and children under the age of ﬁve.5
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II. Introduction
Mali has one of the highest maternal mortality rate in the world: 528 deaths per 100,000 live 
births1. The death rate of children under ﬁve is also very high: almost one child in ﬁve dies be-
fore reaching his or her ﬁfth birthday2.
In Mali, 72% of the population lives below the internationally-recognised extreme poverty line, 
and 63% lives below the national poverty line3. According to the UNDP human development in-
dex, Mali ranks number 173 among the 177 countries surveyed4. 
Mali is divided into health zones where community health associations (ASACOs) create and man-
age community health centres (CSCOMs). The CSCOMs are the ﬁrst step in a health pyramid that 
provides the minimum activity package. This system was set up at the beginning of the 1990’s in 
the context of the Bamako Initiative. According to a principle of recovering the cost of consulta-
tions and medicines, users pay directly for their health care and thus contribute to the manage-
ment of the centres. CSCOMs use referral health centres (CSREF) as their primary reference.
One of the main objectives of the Malian “Health and Population Policy” is to ensure the availabil-
ity of essential drugs and medical consumables, by making them geographically and economi-
cally accessible to the population. In practice, despite an increasing number of health centres, 
the use of curative consultation services remains low: from 0.18 new consultations per inhabitant 
during 1998 to 0.21 in 2003, compared with a forecast of 0.55. The health and social development 
programme (PRODESS)6 highlights the economic difﬁculties of households, as well as a lack of 
information, both of which signiﬁcantly hinder access to basic health services.
Some information about malaria 
Each year, more than 500 million people in the world contract malaria. In Africa, malaria 
is one of the main causes of mortality in children under the age of ﬁve. For other popula-
tion’s groups in the world’s poorest countries, the social and economic consequences are 
also considerable7. 
   
1. EDSM-III and www.undp.org 
2. Demographic and Health Survey, EDSM-IV, preliminary report, 2006.
3. www.undp.org 
4. http://hdr.undp.org/statistics/data/countries 
5. PRODESS II, Health and Social Development Programme, health component, May 2004.
6. Ibidem
7. World Malaria Report, WHO, 2005.8
Since 2001, WHO has recommended using artemisinin-based combination therapy as the 
ﬁrst line malaria treatment. Indeed, in most regions in the world, chloroquine, which used 
to be the cheapest and most widespread anti-malaria drug, has lost its therapeutic ef-
ﬁcacy due to the development of resistance. 
Today, several studies show that a combination of mosquito nets and the availability of 
effective treatment can signiﬁcantly reduce mortality rate8.
The current challenge is to ensure that these prevention and care measures (diag-
nosis and effective treatments) are accessible to populations in need. Covering such 
needs is essential in order to have an impact on mortality and morbidity. 
Several international organisations, governments, NGOs, and research institutes have 
adopted the ﬁght against malaria as one of their priorities. Ambitious world objectives 
have been launched regarding the reduction of malaria-related mortality and morbidity:
 “Roll Back Malaria” partnership – to reduce the mortality rate caused by malaria by 
half between now and 2010, then by half again before 2015;
Millennium Development Goals - Halt and begin to reverse the incidence of malaria and 
other major diseases before 2015;
The Abuja Declaration – African Summit on Roll Back Malaria – to enable at least 60% of 
those suffering from malaria in Africa to have prompt access to treatment by 2005 and 
are able to use correct, affordable and appropriate treatment within 24 hours of the 
onset of symptoms; to enable at least 60% of those at risk of malaria to beneﬁt from 
the most suitable combination of personal and community protective measures, such 
as insecticide treated mosquito nets. At least 60% of all pregnant women who are at 
risk of malaria to have access to presumptive intermittent treatment.
8. “Impact of long-lasting insecticidal-treated nets (LLINs) and artemisinin-based combination therapies (ACTs) measured using  
  surveillance data, in four African countries”, preliminary report, January 2008, WHO.9
II.1   Malaria: a public health problem in Mali 
Even though the entire population of Mali is subject to malaria, the disease is endemic particu-
larly in the Central and Southern regions and potentially epidemic in Northern areas. Malaria is 
characterised by an intense transmission period during the rainy season, the length of which var-
ies depending on each zone. It constitutes the main cause of mortality and morbidity in Mali, es-
pecially in children under the age of ﬁve. On average, children under ﬁve suffer from two episodes 
of malaria per year, while those over ﬁve suffer from one episode of malaria per year9. 
More than 30% of consultations in health structures are linked to malaria; for 2005 alone, more 
than 960,000 cases of malaria were recorded in public health centres10. This number illustrates 
only a small part of the reality, since the number of patients visiting such centres is exceedingly 
low. Rather, the majority of presumed malaria cases are taken care of by people using available 
means in their homes or at community level11.
“National Malaria Control Policy”12 
The aim of the “National Malaria Control Policy” is to reduce mortality and morbid-
ity caused by malaria. The main strategies of this policy include the management of all 
malaria cases as well as preventive measures (chemoprevention during pregnancy and 
vector control) and monitoring, prevention and management of epidemics. 
Confronted with increased resistance to chloroquine13, in 200514, the Government of Mali 
decided to abandon chloroquine in favour of artemisinin-based combination therapies 
(ACTs).
The artesunate/amodiaquine (AS+AQ) combination has been chosen for treating uncom-
plicated cases of malaria; it is used following a laboratory conﬁrmation or after a rapid 
diagnostic test (RDT). National policy also plans for the RDTs and treatments to be ad-
ministered at no cost for children under the age of ﬁve. Quinine will also be used to treat 
serious and complicated malaria cases. Such cases must be treated at the secondary care 
level.
9.    Acceleration Plan for Malaria Control Activities, Ministry of Health, Republic of Mali, April 2007 (“Plan d’accélération des activités de  
  lutte contre le paludisme”). The strategic plan for combating malaria provides an annual estimation of the number of malaria bouts  
  in children under the age of ﬁve and those between ﬁve and eight years old.
10.  Acceleration Plan for Malaria Control Activities, Ministry of Health, Republic of Mali, April 2007.
11.    Information  from the National Malaria Control Policy, Ministry of Health, 2006.
12.  ibidem
13.  Chloroquine resistance level exceeds 25% in the sites observed. At this threshold level, WHO recommends a change in the  treatment  
  protocol. Source: National Malaria Control Policy, Ministry of Health, 2006.
14.  This decision was then recorded in the malaria control national policy document, July 2006.10
Main results expected between now and 201115:
•  At least 80% of those suffering from uncomplicated malaria will beneﬁt from early 
diagnosis and effective treatment using artemisinin-based combination therapy in 
health centres.
•  At least 80% of children under the age of ﬁve with fever/malaria will beneﬁt from 
proper treatment within 24 hours of the ﬁrst symptoms.
15.  Malaria Control Strategic Plan 2007-2011, Ministry of Health, Republic of Mali, July 2006 
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II.2   The Médecins Sans Frontières and health authorities’ project    
  within the Kangaba health Circle
Although Mali is a stable country, MSF, as a humanitarian medical NGO, is still present. The 
high mortality rates – 1.9 deaths in 10,000 persons per day for children under the age of ﬁve 
– mainly due to malaria, as observed in 2005, as well as the lack of effective treatments, led to 
the decision to continue a health care project in Mali16. 
Several studies revealed high levels of resistance to anti-malaria drugs: for example, in 2003, a 
study carried out by Epicentre, in the region of Sikasso, in collaboration with the Malian Depart-
ment of Epidemiology for Parasitic Infections (Département malien d’Épidémiologie des Affec-
tions parasitaires - DEAP) and the Malaria Research and Training Centre (MRTC) in Koumantou 
revealed an excessively high therapy failure rate for chloroquine (90.5%)17.
Consequently, MSF decided to intervene with the purpose of reducing mortality and morbidity 
linked to malaria. The project aims to support the Malian health authorities in implementing 
their new treatment protocol against malaria.
MSF support in the Kangaba Circle started in August 2005 with the introduction of an effective ar-
temisinin-based treatment (RDTs and ACTs) in seven CSCOMs and in the CSREF (for the inpatient 
department) within the Circle18. These centres serve an area where the total population is more 
than 70,000.
The main town of the Kangaba health Circle located 90 km (56 miles) southwest of Bama-
ko, has a population of almost 100,00019. The Kangaba Circle has ten major health zones 
organised around the same number of community health centres (CSCOM).
The climate in Kangaba has two seasons: a dry season from November to April and a rainy 
season from May to October. Therefore a period of high malaria transmission occurs from 
July to December, and a period of low transmission takes place from January to June
 
 
 
   
16.  “Accès aux soins de santé primaires au Mali - résultats d’une enquête épidémiologique” (Access to Primary Health Care in Mali,  
  results of an epidemiological survey) survey carried out within the Bougouni Circle, region of Sikasso. 
  Médecins Sans Frontières, June 2005.
17.   Xavier de Radigues et al., 2004. “Efﬁcacy of Chloroquine and Sulfadoxine-pyrimethamine for the Treatment of Uncomplicated 
  Falciparum Malaria in Koumantou, Mali” 
18.  In January 2008, this support was extended to an 8th CSCOM.
19.  1998 DNSI population survey, updated by the DESAM software of the DN.12
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III.1  MSF support
During the ﬁrst phase of the project, MSF provided assistance to seven CSCOMs and the CSREF.
a. Support to the CSCOMs
At CSCOM level, the priority was to withdraw chloroquine from the national drug supply system 
and to replace it with an RDT and ACT “package”, while at the same time training staff to use the 
new drug protocol. In addition, efforts were made to increase the population’s awareness of ma-
laria, availability and effectiveness of the new treatment, and possible prevention measures. This 
phase has been materialised through the training of community workers.
As well, MSF has boosted the distribution of insecticidal-treated mosquito nets for all babies up to 
11 months – in the context of routine vaccine programmes – and for pregnant women, at the time 
of their ﬁrst antenatal consultation .
Likewise, intermittent presumptive treatments20 have been administered to pregnant women dur-
ing antenatal consultations from the second trimester of pregnancy onwards.
b. Support to the CSREF
At the CSREF level, the priority has been to ensure proper health care for patients, referred by the 
CSCOMs, who suffer from serious and complicated malaria.
To accomplish this, MSF has reinforced the referral system with ambulances, transfusion safety, 
technical assistance, the training of CSREF health workers, and the supply of essential drugs 
(ACTs, Artemether, Quinine, etc.) and medical equipment (RDTs, laboratory equipment, etc.).
III. First phase of the project: August 2005 – November 2006
20. Intermittent preventive treatment using sulfadoxine-pyrimethamine.14
III.2  The cost of health care for the population
From the start of the project, MSF decided to subsidise RDTs and ACTs in order to reduce costs 
for the general public.
Summary: 
The payment system is maintained except for RDTs and ACTs which are: 
>  free of charge for children under ﬁve
>  85 FCFA21 for all other persons.
This strategic choice is based on experience MSF gained in other contexts and on data gathered 
during a survey on access to health care in the Bougouni Circle22.
21.  FCFA: local currency
22.  “Accès aux soins de santé primaires au Mali - résultats d’une enquête épidémiologique” (Access to Primary Health Care in Mali, 
  results of an epidemiological survey) survey carried out within the Bougouni Circle, region of Sikasso. Médecins Sans Frontières,  
  June 2005. See www.accesstohealthcare.msf.be 
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Health care survey carried out in 2005 by MSF in Bougouni, in the region of Sikasso23.
In 2005, MSF conducted a mortality and access to health care survey in Bougouni, in the 
region of Sikasso24. The results showed an exceedingly high mortality rate as well as 
considerable exclusion from health care. 
Mortality rate 
>  The crude mortality rate was 0.8 deaths per 10,000 persons per day. For children 
under the age of ﬁve, the rate was 1.9 deaths per 10.000 persons per day; close to 
the emergency threshold of 2 deaths per 10,000 persons per day. 
>  Families reported that the primary cause of illness was fever, especially in children 
under the age of ﬁve; fever accounted for 43% of all deaths within this age group. 
Access to health care
>  One patient in ﬁve was completely excluded from health care, even though the 
family considered that health care was necessary. A lack of funds was the primary 
reason given by families who had not sought health care.
>  98% of families lived below the poverty line. The average income per person and 
per day amounted to 60 FCFA ; an extremely low amount.
>  Families said that on average, the cost of an episode of illness amounted to 4,000 
FCFA, equivalent to two-month’s income.
>  At the time of the survey, the exemption system for the indigent was not operating 
efﬁciently; it protected less than 2% of the population.
MSF decided to donate the RDT and ACT package to CSCOMs so that it would be administered 
free of charge to children under the age of ﬁve. For adults, the package would be sold at the same 
price as chloroquine, 85 FCFA.
The rest of the ﬁnancial contribution system for patients within the CSCOMs was not modiﬁed. In 
practice, this means that the ﬁnancial barrier was lowered only for the RDT and ACT package. For 
other prescribed drugs, as well as for consultation costs, the cost recovery system was unmodi-
ﬁed. According to data available at the start of the project, consultation costs varied between 400 
and 600 FCFA in a CSCOM and 1,000 FCFA in the CSREF.
23  Ibidem
24  Ibidem
25  Conversion rate used at the time of the survey: 500 FCFA = $US1.16
III.3  Summary of the main results of the initial phase of MSF support to  
  the CSCOMs of the Kangaba Circle 
a. Strengths and Weaknesses
Strengths
>  RDT and ACT: available
>  Malaria diagnosis: improved 
>  Treatment of diagnosed malaria: improved 
>  Acceptance of new treatments by the population: good 
Weaknesses
>  CSCOM attendance: on the increase, although still too low
>  Qualiﬁcation and motivation of CSCOM staff: insufﬁcient
b. Main results
  i. Use of RDTs has improved diagnosis within the CSCOMs
The use of RDTs has turned out to be crucial: they have enabled better use of new treatments, 
which are only administered after a biological conﬁrmation through the test. Moreover, health 
workers have been able to give a diagnostic to fever cases other than malaria. Patients with fever, 
but whose RDT was negative, were given proper treatment as soon as a correct diagnosis was 
made. 
 High transmission26   Low transmission27 
Conﬁrmed percentage of malaria on the 
total number of patients tested 
66%  43%
Conﬁrmed percentage of malaria on the 
total number of children under ﬁve tested 
77%
 
53%
Note: All patients with fever, or having had fever within two days prior to consultation, are tested. 
Finally, proper diagnosis prevents the development of resistance to treatments by limiting their 
use to conﬁrmed cases.
26. Data from the high transmission period in 2005.
27. Data from the low transmission period in 2006.17
  ii.   Introduction of RDTs, ACTs, and new protocol has considerably improved 
    treatment within the Centres
In the second half of 2005, 93% of patients suffering from conﬁrmed malaria (conﬁrmed by using 
RDTs) were treated with ACT in the supported CSCOMs; 3% were treated with Quinine (pregnant 
women). In total, 96% of malaria cases were properly treated. 
In 2006, in the supported CSCOMs, 95% of patients suffering from conﬁrmed malaria (using RDTs) 
were treated with ACTs. The other 5% were treated with Quinine (pregnant women) or injectable 
Artemether for serious and complicated malaria cases.
In addition, the quality of diagnosis of serious malaria has improved: 452 cases were diagnosed 
in 2006 compared with 14 in 2005.
  iii.   Although attendance at the CSCOMs has increased, it remains too low    
    in relation to needs
Utilisation of services at the CSCOMs considerably increased in 2005 and 2006. A comparison of 
the attendance rates in 2004 and 2006 shows an increase of almost 60%.
An increase in the overall use of health services can be analysed in terms of the total number of 
visits to health centres, regardless of diseases, and according to the number of malaria cases 
treated. These two analysis are presented below: 
Increase in overall attendance at the seven CSCOMs from 2002 to 2006 
The table below shows the attendance rate, expressed in new curative consultations (NCs) per 
inhabitant and per year, all pathologies combined. The reference population covered by the seven 
MSF-supported CSCOMs is 66,479 people in 2005 and 71,158 in 2006.
These results show that an upward trend had already started prior to MSF’s intervention.   
Nevertheless, the greatest increase took place in 2005 and 2006, after the start of the project.
2002 2003 2004 2005 2006
0,6
0,4
0,2
0
expected attendance in rural areas (WHO)
new curative consultations/inhabitant/year
0,14 0,15
0,17
0,22
0,2718
Malaria cases are the main reason for the increase in attendance during 2005 and 2006. This can 
be explained by
>  The effectiveness of new malaria treatments available in the CSCOMs (compared 
with the therapeutic ineffectiveness of chloroquine);
>  The awareness campaigns on the introduction of the RDT and ACT package carried 
out by health workers;
>  The reduced cost of the RDT and ACT package (free-of-charge or reduced price);
>  MSF’s presence and the efforts to improve quality of care.
Despite the observed increases, these attendance rates remain low in comparison with the 
WHO reference rate, which is 0.6 new curative consultations per inhabitant and per year in 
rural areas28. 
Similarly, for malaria, where the average morbidity rate is one or two episodes per person 
(depending on the age group)29, there are signiﬁcant limitations in terms of the coverage of 
needs. 
 
Increase in overall malaria treatment in the seven CSCOMs from 2005 to 2006
From 2005 to 2006, the number of malaria cases treated in the CSCOMs increased by more than 
20%: 
>  In 2005, 6,644 cases of malaria were treated; in average annual ﬁgures, that is 0.10 
malaria cases treated per inhabitant.
>  In 2006, 8,169 cases of malaria were treated; that is 0.12 malaria cases treated per 
inhabitant. 
Despite these increases, the coverage of actual needs has remained very low, compared with 
the number of expected malaria cases.
For children under the age of ﬁve 
>  In 2005, 3,018 cases of malaria were treated; that is, 0.25 bouts of malaria treated 
per child per year30.
>  In 2006, 4,622 cases of malaria were treated; that is, 0.38 bouts of malaria treated 
per child per year, equal to an increase of over 50% from 2005 to 2006.
 
28. Health Information System, AEDES
29. Acceleration Plan for Malaria Control Activities, Ministry of Health, Republic of Mali, April 2007.
30. During the ﬁrst seven months of the year, this refers to presumptive malaria.19
Considering that, on average, children under ﬁ  ve suffer two episodes of malaria per year, these 
ﬁ  gures reveal signiﬁ  cant limitations in terms of access to treatment by this vulnerable group. 
In the under-ﬁ  ve age group, less than one episode of malaria out of ﬁ  ve is treated in a CSCOM.
3
2,5
2
1,5
1
0,5
0
bouts of malaria not treated
in the CSCOM
New malaria cases diagnosed/child/year
2005 2006
0,25 0,38
For persons over the age of ﬁ  ve 
>  In 2005, 3,626 cases of malaria were treated; that is, 0.07 episodes of malaria treated 
per person, per year. 
>  In 2006, 3,229 cases of malaria were treated; that is, 0.06 episodes of malaria treat-
ed per person per year, equivalent to a reduction of 11% from 2005 to 2006. This 
reduction is explained by the introduction of RDTs, which enabled the correct diagno-
sis of malaria cases during the low transmission period in 2006. As shown in the fol-
lowing graph, there was more than a 50% reduction in the number of cases between 
2005 and 2006, during the low transmission period. This reduction is evidence of the 
importance of the rapid tests for correctly diagnosing fever cases.
1322
2006 2005
New malaria cases diagnosed      low transmission      high transmission
3000
2500
2000
1500
1000
500
0
2006
2304
585
266420
Given that, on average, people over ﬁve suffer one episode of malaria per year, these numbers 
conﬁrm the signiﬁcant limitations in terms of access to anti-malaria treatment for this age 
group: in the over-ﬁve age group, less than one episode of malaria out of ﬁfteen is treated in a 
CSCOM. 
Moreover, throughout this period, ACTs were not found to be available elsewhere in the Circle (i.e., 
beyond the MSF- supported CSCOMs).
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III.4   Conclusions of the ﬁrst phase of the MSF project in Kangaba
MSF’s intervention in the Kangaba Circle was aimed at reducing mortality and morbidity linked 
to malaria by making effective new anti-malaria treatments available. The initial assumption 
was that making low-priced RDT and ACT packages available in the CSCOMs would ensure that 
patients in need would have ready access.
Upon conclusion of the ﬁrst phase, the results were mixed.
The availability of RDT and ACT packages in the supported health centres was assured, and this 
led to improved diagnosis and enhanced treatment of conﬁrmed malaria cases.
The availability of RDT and ACT packages, combined with efforts to improve quality of care and 
population-awareness campaigns on the availability of new treatments, have helped to increase 
attendance at the centres. From 2005 to 2006, the number of conﬁrmed malaria cases treated in 
the CSCOMs increased by more than 20%.
However, despite these improvements, community level health centres were largely underused. 
For cases of malaria, the coverage remained extremely low, especially when compared with the 
estimated need.
>  For children under the age of ﬁve, only one episode of malaria out of ﬁve was treated 
in a CSCOM. 
>  For persons over the age of ﬁve, less than one episode of malaria out of ﬁfteen was 
treated in a CSCOM.
Such coverage of malaria cases is very low, especially as use of services is seen as essential in 
terms of combating malaria31 and for reducing mortality and morbidity throughout the popu-
lation. 
In a context where the availability of effective treatment and the quality of health care had 
already improved, the main reason identiﬁed for the weak use of health services was the ﬁnan-
cial obstacle, due to widespread poverty. Geography was also a factor limiting access to care, 
especially for people living in some isolated villages with difﬁcult access during the winter. 
Additional effort, in terms of quality health care in the CSCOMs and staff motivation, was also 
required.
The focus on AVAILABILITY of effective treatment in the health centres failed to solve the prob-
lem of ACCESS to health facilities, and therefore the achievement of targets for reducing mor-
tality and morbidity due to malaria was greatly limited. The assistance provided by MSF to the 
CSCOMs beneﬁted only a limited number of people.
31.  « Peut-on contrôler la malaria dans les endroits où les services de santé de base sont sous-utilisés? » (Can malaria be controlled in 
areas where the basic health services are underused?) Unger et al., Tropical Medicine and International Health, Volume 11, mars 2006.22
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The second phase of the project is ongoing; the results and analyses described in this section 
refer to the period from December 2006 to December 2007.
IV.1  MSF support
The support offered during the ﬁrst phase has been maintained at the CSCOMs and the CSREF 
level and additional measures have been implemented to:
>  Enhance the quality of administered health care
  Staff training programmes have been implemented in the CSREF, with special at-
tention paid to treatment protocols for common diseases and also to serious or 
complicated malaria cases. The system of referral for patients to the CSREF has 
also been improved.
>  Increase attendance in health centres through free care policy implementation
  By providing health care free-of-charge, CSCOMs incur a loss of revenue. The costs 
that are not collected from patients must be replaced by other ﬁnancial sources. In 
this project, MSF subsidises the existing system by paying in lieu of the patient.
  Financial compensation is organised in the form of a ﬁxed sum paid to the commu-
nity health associations (ASACO). These sums serve to cover the running costs of 
the CSCOMs, as well as the staff motivation premiums. Salaries not covered by the 
national scheme are also ﬁnanced by MSF. 
  The CSREF is supplied with medicines to ensure free treatment for medical cases in 
children under the age of ten. Financial compensation also guarantees transporta-
tion of patients to the CSREF and free treatment.
>  Improve geographical access to health care
  A system of Malaria Village Workers (MVW, “agents palu”) was put in place in order 
to reach patients living in remote areas, far from the health centres, with particu-
larly difﬁcult access in the rainy season. In these areas, during the high-transmis-
sion period, MVW administer free treatment for conﬁrmed malaria cases in children 
up to ten. 
IV. Second phase of project – from December 200624
Malaria Village Workers (MVWs) 
To overcome the geographical barrier to access to health centres, in July 2007, MSF set 
up a network of community village workers to bring treatment closer to the population.
A MVW is responsible for administering free treatment for uncomplicated malaria to chil-
dren up to the age of ten. Throughout the high transmission period for malaria, the MVW 
works in villages and hamlets located over 5 km (3 miles) from the health centres. 
MVWs are employed from within the communities, which elect them and grant them le-
gitimacy. They live in the villages and are under contract with the ASACO, which in turn 
grants them a small motivational bonus through ﬁnancial support provided by MSF. They 
are supervised by the CSCOM nearest to 
their  area  of  activities  and  two  nurses 
oversee  their  training  and  performance. 
MSF trains the MVWs and provides them 
with equipment necessary for their activ-
ity. Their presence in the villages enables 
early intervention in case of fever.
A MVW is equipped with all the tools re-
quired for accomplishing his or her task: 
RDT  and  ACT  packages,  Paracetamol, 
gloves, basic medical equipment, a bicy-
cle, identiﬁcation equipment, etc.
The treatment of a patient begins after di-
agnosis using an RDT. An RTD is simple to 
use and ensures that the ACT treatment is administered only to people with fever whose 
diagnosis has been conﬁrmed. Negative RDTs and cases that have complications are 
referred to the CSCOMs where patients are cared for, either free of charge or for a ﬁxed 
sum of 200 FCFA for those over 10 years old. The MVW’s role is extremely limited, which 
facilitates the monitoring of their activities. 
The results for the 2007 high-transmission period are encouraging. During this period, 
MVWs treated 7,159 cases of malaria in children ten years old and under.25
IV.2 Changes in health care fees as of December 2006
Free health care for the under ﬁves and pregnant women
Following the results of the ﬁrst phase of the project, MSF, together with the regional and local 
authorities, decided to abolish the ﬁnancial barrier for the most vulnerable patients: children 
under the age of ﬁve and pregnant women. The aim was also to reduce ﬁnancial constraints for 
other population groups. This strategy has been implemented in the seven CSCOMs supported 
by MSF within the Kangaba Circle.
Since December 1, 2006 
>  Children under the age of ﬁve beneﬁt from free health care for all diseases. The 
free-of-charge  policy  applies  to  the  complete  case  management  (consultation, 
tests, treatments, referral, and admission to hospital at the CSREF), regardless of 
the disease diagnosed. At the referral health centre (CSREF), children 10 years and 
under are treated for free for severe malaria and associated pathologies. 
>  Pregnant women beneﬁt from free health care for cases of fever. The free-of-
charge policy applies to all the costs linked to the illness (consultation, tests, treat-
ments and referral).
>  People over the age of ﬁve beneﬁt from a reduced ﬁxed sum of 200 FCFA for health 
care for cases of fever32. This price includes all expenses linked to an episode of 
sickness (consultation, tests and treatments, as well as the transportation of re-
ferrals to the CSREF). For other pathologies, pricing falls under the existing cost 
recovery system. 
Summary of changes in health care costs in the CSCOMs of Kangaba: ﬁrst phase and    
second phase
32. The ﬁxed rate sum for those over the age of ﬁve was introduced progressively: ﬁrst in three CSCOMs, from December 2006 to June 
2007; then, in all seven supported CSCOMs, from July 2007. 
cost recovery cost recovery except for
RDT + ACT free for children
85 FCFA for adults
under 5 years: overall free health care
fever pregnant women: free care
fever + 5 years: 200 FCFA (3 CSCOM then 7)
2005 2006 2007
Kangaba 1st phase Kangaba 2nd phase
August 2005
start of MSF support
Decembre 2006
project reorientation:
modiﬁed health care prices26
Free health care for target groups: a strategy to increase malaria case management
In a context where patients have to pay for other health care services, the availability of free and 
effective malaria treatment was insufﬁcient to make a signiﬁcant impact on the use of health 
services. The decision regarding the new strategies was based on the results of the ﬁrst phase 
of the Kangaba project, on the data available from the Bougouni Circle33, and on MSF experience 
elsewhere about the positive impact of abolishing the user fees34. 
This targeted no-charge strategy is aimed at removing the ﬁnancial barrier to care. However, if 
the ﬁnancial barrier is removed for malaria alone, a signiﬁcant uncertainty remains concerning 
the diagnosis that will be made at the health centre and therefore the amount that will be charged 
to a patient. In a context of widespread poverty, such uncertainty can dissuade families from going 
to the CSCOM or, at least, can postpone such a decision.
By adopting an overall strategy of free care for any episode of fever, or all other pathologies, 
among children under the age of ﬁve, this pitfall is avoided. In this way, a very clear message is 
given to people about the amount they need to pay:
>  For all fever cases, no charge for pregnant women and children under the age of 
ﬁve, 200 FCFA for persons over the age of ﬁve 
>  For illness in children under ﬁve, no charge
This speciﬁc information encourages families to go to the CSCOM quickly in the event of sickness, 
as early treatment is crucial, especially for malaria. Furthermore, children under the age of ﬁve 
are particularly vulnerable, as conﬁrmed by the mortality rate for this group, not only in Mali35 . but 
also in many other African contexts36. Facilitating their access to health centres would seem to be 
an essential strategy for all pathologies, and is part of the WHO recommendations37.
33.  “Accès aux soins de santé primaires au Mali - résultats d’une enquête épidémiologique” (Access to Primary Health Care in Mali,  
  results of an epidemiological survey); survey carried out within the Bougouni Circle, region of Sikasso, Médecins Sans Frontières,  
  June 2005.
34. See also the MSF report, “No cash, no care”, available at www.accesstohealthcare.msf.be 
35. Demographic and health survey, EDSM-IV, preliminary report, 2006.
36. Refer to Website: www.who.int 
37.  “Making every mother and child count,” WHO, World Health Report, 2005.   27
IV.3  Summary of the main results of the second phase of MSF support to    
  CSCOMs of the Kangaba Circle 
a. Strengths and weaknesses
Strengths (in comparison to the ﬁrst phase) 
>  Curative consultations: trebled 
>  Attendance rate for target groups:
  for pregnant women, an increase from 0.3 to 1.1 new consultations per person per 
year
  for children under ﬁve, an increase from 0.67 to 2.86 new consultations per person per 
year
>  Cases of treated malaria: multiplied by 3.5 in the under-ﬁve age group
>  Cases of serious malaria: fewer cases seen in the CSCOMs (reduced from 6% to 
1.7%)
>  Case fatality rate linked to malaria in the CSCOMs: reduced from 0.35% to 0.03% 
Weaknesses
>  Ability to make differential diagnosis in the CSCOMs: to be reinforced
>  The quality of care and free-of-charge policy at the CSREF: to be improved
>  Follow-up on pre-referrals (from MVWs to the CSCOMs) and referrals (from CSCOMs 
to the CSREF): to be reinforced28
b. Talking points on the main results
  i. Curative consultations (all pathologies)
> Major increase in attendance rates in terms of curative consultations
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Following the implementation of new strategies in the second phase of the project, the total 
number of consultations has seen a remarkable increase:
>  It trebled in relation to 2006 
>  It quadrupled since the start of activities. 
The attendance rate has increased from 0.27 to 0.84 new consultations per inhabitant per year 
during the period 2006 to 200738. 
38.   If the number of patients coming from outside the CSCOMs catchment area are deducted, the ﬁ  gures would be 0.21 NC in 2005, 0.26 
NC in 2006, and 0.79 in 2007.
0,22 0,27
0,8429
> Major increase in number of visits to the CSCOMs by vulnerable groups
The following table compares the attendance rate for each age group, for all types of pathology.
2005 2006 2007
3,00
2,00
1,00
0,00
>  For the under-ﬁve age group the attendance rate multiplied by 4.2 between 2006 
and 2007, reaching 2.86 new consultations per child per year. 
>  For pregnant women, the attendance rate multiplied by 3.6 between 2006 and 2007, 
reaching more than one new curative consultation per woman and per year (1.12 
new consultations).
>  For people over the age of ﬁve, the attendance rate multiplied by 1.8 between 2006 
and 2007; 0.35 new cases per inhabitant over the age of ﬁve.
The greatest increase in attendance is seen among children under the age of ﬁve and pregnant 
woman, the very groups who were targeted by free care measures.
For the group comprising persons over the age of ﬁve for whom the fee reductions were less 
substantial, attendance remained quite low, particularly in relation to the expected number of 
malaria cases per year in adults (one bout a year for the over-ﬁve group39). 
0,45
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0,31
0,67
2,86
1,12
0,35
  
< 5 years                > 5 years              Pregnant women
39.  Acceleration Plan for Malaria Control Activities, Ministry of Health, Republic of Mali, April 2007.30
  ii. Consultations linked to malaria
> Total number of treated malaria cases has trebled 
The following graph shows the evolution of malaria treatment administered in the MSF-supported 
CSCOMs and the number of cases treated per inhabitant per year. 
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An annual average of 0.35 cases of malaria per inhabitant was treated in the CSCOMs, i.e. over 
three times more than before the price change. This number indicates that many people suffer-
ing from malaria were not treated in the CSCOMs prior to the changes in the fees. The suppres-
sion of the ﬁ  nancial barrier now enables people to seek health care when needed.
> For children under the age of ﬁ  ve, the number of treated malaria cases has multiplied by 3.5.
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This data illustrates a considerable improvement in the coverage of needs: in 2007, more than one 
case of malaria per child was treated in the CSCOMs. In reference to the average known levels of 
malaria disease for this age group in Mali, this improvement represents a 64% coverage of total 
needs, compared with less than 20% coverage in the ﬁ  rst phase of the project.31
In 2007, 16,819 cases of malaria were treated:
>  35% of the total cases (5,919 consultations for uncomplicated malaria only) were 
treated by MVWs
>  65% (10,900 consultations) were treated in the CSCOMs 
>  For persons over the age of ﬁve, the number of malaria cases treated was multiplied                    
  by  2.2
1,20
1,00
0,80
0,60
0,40
0,20
0,00
1 bout of malaria expected per person 
per year
   
New malaria consultations/> 5 years/year
2005 2006
0,07 0,12
0,06
2007
Coverage, in terms of treating malaria cases, has improved since the ﬁrst phase of the project. 
Nevertheless, it remains far too low for this age group: only one case out of eight is treated in the 
CSCOMs, and this in a context where one episode of malaria is expected per year for persons over 
the age of ﬁve40. 
In 2007, there were 7,184 malaria consultations for those over ﬁve years old: 
>  17% (children aged ﬁve to ten with uncomplicated malaria only) were treated by 
MVWs
>  83% were treated in the CSCOMs.
> For pregnant women, the number of malaria cases treated has increased ﬁvefold. 
In 2007, 1,639 pregnant women were treated for malaria, which corresponds to 0.45 new cases 
per person per year for this age group; that is ﬁve times more than in 2006 (338 cases were 
treated, corresponding to 0.09 new cases per person per year).
40.    Acceleration Plan for Malaria Control Activities, Ministry of Health, Republic of Mali, April 2007.32
iii. Consultations other than malaria
  Attendance for reasons other than malaria has trebled
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Note: data concerning consultations for pregnant women are unavailable for 2005.
While the number of curative consultations linked to malaria trebled, the number of consulta-
tions linked to complaints other than malaria has also trebled. In 2007, there were 24,000 more 
consultations than there were in 2006.
The increase in attendance was the highest in groups that beneﬁ  ted from free treatment:
>  For children under the age of ﬁ  ve non-malaria consultations increased ﬁ  vefold. 
The main pathologies treated during 2007 were infections of the upper and lower 
respiratory tract and other infections, as well as diarrhoeal disease.
>  For pregnant women, the number of consultations trebled. The main pathologies 
treated in 2007 involved sexually-transmitted infections, respiratory tract infections 
and other infections, as well as diarrhoeal disease.
Increased attendance of these most vulnerable groups is crucial for improving overall population 
health and reducing maternal and child mortality, both of which are very high in Mali. The aboli-
tion of ﬁ  nancial barriers for the under ﬁ  ves is one of the priority measures proposed to reduce the 
mortality rate for this age group and achieve the MDGs41. 
41. Quick-win actions to reach the MDGs: “eliminating user fees for basic health services in all developing countries, ﬁ  nanced by in-
creased domestic and donor resources for health.” See Website: www.unmillenniumproject.org 33
iv.  Impact of measures on the reduction of the mortality rate in the seven MSF-sup-
ported CSCOMs within the Kangaba Circle.
To date, no population survey has been carried out in the Circle to measure the impact of health 
care coverage improvement on mortality rate and particularly for malaria. A retrospective survey 
is being planned to gather information on mortality rates outside the health centres. Neverthe-
less, some encouraging trends from 2006 to 2007 have already been observed at CSCOM level:
>  The percentage of malaria cases treated that were severe malaria cases fell from 
6% to 1.7% . This decrease shows that early and effective treatment of malaria helps 
prevent the development of severe forms of malaria, and this probably leads to the 
reduction of related deaths. 
>  The case fatality rate for malaria fell tenfold across the CSCOMs , from 0.35 to 
0.03%. This decrease also indicates that early and effective treatment of malaria 
leads to a reduction in the mortality risk42. 
 
42. Such data should be complemented by case fatality data for severe malaria in the CSREF. A comparison of the 2006 and 2007 data is not 
possible at this level due to the unavailability of reliable data for 2006.
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IV.4  Conclusions of the second phase of the MSF project in Kangaba
The conclusions of the ﬁrst phase of the project showed that the presence of MSF within the 
Circle, combined with efforts to increase the availability of effective malaria treatment in the CS-
COMs, helped to improve health care for patients. Attendance in the centres also increased, al-
though the level reached did not allow for adequate coverage of needs, especially for cases of 
malaria, the project’s target pathology. 
The conclusions of the second phase of the project are very encouraging: The strategy to reduce 
ﬁnancial barriers has produced direct results that are both clear and being sustained over time. 
In comparing the second phase of the project to the ﬁrst phase:
>  The total number of curative consultations has trebled;
>  The attendance rate for children under ﬁve has quadrupled;
>  The attendance rate for pregnant women has multiplied by 3.5;
>  The total number of malaria cases treated has trebled;
>  Severe malaria cases and the number of deaths due to malaria in the CSCOMs have 
decreased.
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These results clearly indicate the improved coverage of the health needs of the population 
within the area, particularly for vulnerable groups and for malaria cases where early and ef-
fective treatment is crucial for recovery. The established network of MVWs has also contributed 
to efforts directed toward the early treatment of malaria in remote areas during periods of high 
transmission.
These results conﬁrm that free health care for patients, when subsidised to ensure continuation 
and quality of service, has a rapid impact on attendance at health centres. In a context where 
morbidity and mortality linked to malaria are signiﬁcant and where poverty is commonplace, this 
measure seems crucial for a quick improvement of popula-
tion health. It also ensures that the subsidies granted to health 
centres actually reach the people, including the most vulner-
able groups.
Costs required to provide free-of-charge quality health 
care to targeted populations 
The data in this section, collected during the MSF project in 
Kangaba, represent an estimation of the subsidies required 
for obtaining the results presented in this report.  Although 
several parameters may vary depending on the context and the persons involved, the 
data can be used as an indication of the expected costs for implementing this type of 
strategy in other situations.
The project data show that between 2005 and 2007, the total number of consultations 
more than quadrupled within the MSF-supported CSCOMs. Free health care for the tar-
get population was a determining factor, and requires signiﬁcant amounts of ﬁnancing. 
Financing not provided by patient contributions must be replaced in order to guarantee 
the availability of quality health care. It is therefore necessary to subsidise the system in 
order to ensure that the CSCOMs’ main expenditures remain covered.
At the CSCOM, the principal items are drugs, human resources, and operating costs.
In the second phase of the project, in addition to supplying the CSCOMs with RDT+ACT 
packages and essential medicines, MSF subsidised the health care system via grants 
to the ASACOs to enable them to cover other signiﬁcant expenses, such as human re-
sources (salaries and bonuses) and operating costs. In addition to the amount directly 
associated with the activities of the CSCOMs, the costs incurred by the MSF team sup-
porting the system also need to be included. 
“Before, each rainy 
season, I would bury   
children from my village 
two by two.
This year, “Insha’Allah”,    
I have yet to bury one”
Imam de Kalakoro, novembre 200736
Allocation of costs (2007 data)
In terms of CSCOM operating-related costs only (i.e. excluding the support team), the 
expenses can be broken down as follows: drugs 55%, staff-related costs 32%, and 13% 
for running costs. 
Absolute costs (2007 data)
Taking into account the 2007 attendance rate and the price of the drugs supplied by MSF, 
the cost per 1,000 consultations carried out in the CSCOMs averages 2,370 Euros.
By way of comparison 
In 2005, prior to the MSF intervention, when the cost recovery system was in force and 
attendance at the CSCOMs was relatively low, the cost for 1,000 consultations in the CS-
COMs was estimated to be 20% higher than the current cost.
These differences are explained by the principle of economies of scale: in 2005, the low 
number of consultations at the CSCOM was creating relatively higher staff expenses and 
operating costs. 
In 2007, the signiﬁcant increase in attendance at the CSCOMs ensured a more optimal 
use of available resources, thereby enabling economies of scale and a reduction in the 
cost of health care per patient. Economies of scale helped to achieve a reduction of 32% 
in staff expenses and 51% in operating costs per patient.
These results are very signiﬁcant because the increased use of health services proves 
that a strategy of free health care for the patient enables optimal use of resources, 
thereby reducing the cost of health care per patient.
It results in a system which improves coverage and reduces costs per patients, pro-
vided that drug subsidies are supplemented by funds covering CSCOM staff expenses 
and costs of supervision. The data can serve as an indication of the funding required for 
an effective intervention to ensure that subsidies given actually reach the population and 
help to meet their health needs.37
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For several years, the Government of Mali has been involved in ﬁghting malaria, which remains a 
major cause of mortality and morbidity in the country. An important step in the ﬁght against ma-
laria was the change in the national treatment protocol to the new artemisinin-based combination 
therapies, and the withdrawal of chloroquine. Making these treatments accessible to the popula-
tion is clearly part of the national malaria control strategy, which plans for RDTs and ACTs to be 
administered free-of-charge to the under-ﬁve age group, an extremely vulnerable group in terms 
of malaria.
Médecins Sans Frontières, is committed to the ﬁght against malaria in Mali, and introduced RDTs 
and ACTs in August 2005. The project has been operated in close collaboration with the Malian 
health authorities, at local, regional and national levels. The project is, for the most part, based on 
the existing system of CSCOMs and ASACOs in the Kangaba Circle.
After three years of assistance, MSF is keen to share the positive results obtained through this 
pilot project with the various partners involved in ﬁghting malaria in Mali.
The main conclusions of the project are as follows:
>  Introducing the RTD+ACT package in CSCOMs helps improve malaria diagnosis and 
treatment. The training of staff on the new protocol ensures the correct case manage-
ment of a maximum number of patients.
>   Information provided to the population on malaria and effective treatment is crucial. 
With such awareness, new treatments are more readily accepted. 
>  The availability of MSF-subsidised effective treatment in the CSCOMs has helped to 
increase the use of such services signiﬁcantly. However, despite this increase, the 
coverage rate in the ﬁrst phase of the project was inadequate in relation to the needs. 
As a result of the cost recovery scheme in force in the CSCOMs in Mali, many patients 
are excluded from health care due to their inability to pay, despite the RDT+ACT package 
being subsidised. This observation comes from the results of the 18-month programme 
within the Kangaba Circle, where, despite the availability of adequate treatment and 
proper health care for patients, the majority of malaria cases that occurred within the 
community were not treated in the CSCOMs.
>  Abolition of the ﬁnancial barriers for patients – not only for drugs, but also for over-
all free care for the most vulnerable groups – has a huge impact on the attendance. 
This free-of-charge strategy ensures a better coverage of population needs. Hence, 
in the second phase of the Kangaba project, free health-care for children under ﬁve has 
seen attendance increase fourfold for this vulnerable group, and the number of malaria 
cases treated for this group has trebled. Also, free treatment for pregnant women of 
all episodes of fever has trebled their attendance rate. These measures have enabled a 
V.   Overall conclusions 39
better coverage of the most vulnerable groups. It is estimated that more than 60% of 
children under the age of ﬁve suffering from malaria have been treated. 
>  The development of a community MVWs network in areas that are most remote from 
the CSCOMs and least accessible during the rainy season contributes to the early and 
free case management of children under the age of ten in high malaria transmission 
periods.
>  The combination of these different strategies helps to reduce the number of severe 
malaria cases treated in the CSCOMs, as well as the number of deaths due to ma-
laria.
Currently, at the national level, the under-use of the CSCOMs remains the major obstacle in terms 
of improving the malaria case management. This hurdle prevents subsidies already available for 
combating malaria from actually reaching the majority of the population, including the most vul-
nerable. MSF hopes that these data will encourage further considerations of how to subsidise the 
health care system, in order to replace patients payments with funding from other sources.
Beyond the experience of MSF in Kangaba and elsewhere, these measures are recommended at 
the international level with the aim of reaching targets for the reduction of mortality rates among 
the most vulnerable groups, in particular women and children. The provision of subsidies ena-
bling free health care at the point of use is a key measure for guaranteeing effective intervention 
to meet the needs of the population.
Several governments are already committed to this, and some have received international fund-
ing in support of this objective. For example, free health care is available for children under the 
age of ﬁve in Niger; for children under ﬁve and for pregnant women in Burundi; and free for all 
in Uganda and South Africa and, recently, in Sudan. In all cases where results have been docu-
mented, the abolition of ﬁnancial barriers to the patient, accompanied by additional funding from 
other ﬁnancial sources, resulted in a positive impact on attendance rates at health centres44. 
MSF hopes that the conclusions of this pilot project will encourage debate at the national level 
on strategies capable of improving malaria case management in Mali and increasing coverage 
of the health needs of all Malians.
43.  Quick-win actions to reach the MDGs: “eliminating user fees for basic health services in all developing countries, ﬁnanced by  
  increased domestic and donor resources for health.” See Website: www.unmillenniumproject.org  and “Make every mother and  
  child count - access to care and ﬁnancial protection for all”, WHO, World Health Report 2005.
44  . NABYONGO J. et al. (2005). Abolition of cost sharing is pro-poor: Evidence from Uganda, Health Policy and Planning 20(2); p.100-108.  
  Ministry of Health, WHO, Impact of the Presidential Decree on free health care, Burundi, September 2006.Contact information:
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